Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
BI-3810944 in Melanoma: NCT07224425 Clinical Landscape Report 2026
28 September 2026
NCT07224425 clinical landscape for Melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
NTR-1011 in Rheumatoid Arthritis: NCT07237659 Clinical Landscape Report 2026
28 September 2026
NCT07237659 clinical landscape for Rheumatoid Arthritis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Apatinib Mesylate in Recurrent Mucosal Melanoma: NCT07236528 Clinical Landscape Report 2026
28 September 2026
NCT07236528 clinical landscape for Recurrent Mucosal Melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
YTS-109 in Myositis: NCT07236762 Clinical Landscape Report 2026
28 September 2026
NCT07236762 clinical landscape for Myositis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Secukinumab in Metastatic melanoma: NCT07237594 Clinical Landscape Report 2026
28 September 2026
NCT07237594 clinical landscape for Metastatic melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
VENT-03 in Lupus Erythematosus, Cutaneous: NCT07260877 Clinical Landscape Report 2026
28 September 2026
NCT07260877 clinical landscape for Lupus Erythematosus, Cutaneous: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Entinostat in Bladder Cancer: NCT07261592 Clinical Landscape Report 2026
28 September 2026
NCT07261592 clinical landscape for Bladder Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
KN-3601 in Granulomatosis With Polyangiitis: NCT07246096 Clinical Landscape Report 2026
28 September 2026
NCT07246096 clinical landscape for Granulomatosis With Polyangiitis: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
AN-9025 in Solid tumor: NCT07252479 Clinical Landscape Report 2026
28 September 2026
NCT07252479 clinical landscape for Solid tumor: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
EIK-1005 in Microsatellite instability-high colorectal cancer: NCT07262619 Clinical Landscape Report 2026
28 September 2026
NCT07262619 clinical landscape for Microsatellite instability-high colorectal cancer: endpoints, sponsor, phase, geography, readouts, asset context and devel…
9 min read
Dual-targeting BCMA/CD19 CAR-T(Ucello Therapeutics) in Systemic Lupus Erythematosus: NCT07266337 Clinical Landscape Report 2026
28 September 2026
NCT07266337 clinical landscape for Systemic Lupus Erythematosus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
[211At]At-Girentuximab in Non-Muscle Invasive Bladder Neoplasms: NCT07260162 Clinical Landscape Report 2026
28 September 2026
NCT07260162 clinical landscape for Non-Muscle Invasive Bladder Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and development white…